Traders assign an 81.5% probability to no new COVID variant of concern emerging before 2027 because ongoing genomic surveillance shows SARS-CoV-2 continuing to evolve through Omicron sublineages such as XFG without crossing the thresholds for increased transmissibility, severity, or immune escape that would trigger official designation. Recent monitoring reports through April 2026 confirm no variants currently meet variant-of-concern criteria, with strains like BA.3.2 remaining under observation but producing no widespread spikes in hospitalizations or vaccine breakthrough cases. This pattern aligns with the post-Omicron stabilization seen since late 2024, where incremental mutations have prompted routine vaccine updates rather than disruptive new threats.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update$238,975 Vol.
$238,975 Vol.
$238,975 Vol.
$238,975 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Binuksan ang Market: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Traders assign an 81.5% probability to no new COVID variant of concern emerging before 2027 because ongoing genomic surveillance shows SARS-CoV-2 continuing to evolve through Omicron sublineages such as XFG without crossing the thresholds for increased transmissibility, severity, or immune escape that would trigger official designation. Recent monitoring reports through April 2026 confirm no variants currently meet variant-of-concern criteria, with strains like BA.3.2 remaining under observation but producing no widespread spikes in hospitalizations or vaccine breakthrough cases. This pattern aligns with the post-Omicron stabilization seen since late 2024, where incremental mutations have prompted routine vaccine updates rather than disruptive new threats.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong